OGN Relative Valuation
OGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OGN is overvalued; if below, it's undervalued.
Historical Valuation
Organon & Co (OGN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 2.62 is considered Undervalued compared with the five-year average of 5.07. The fair price of Organon & Co (OGN) is between 19.80 to 27.39 according to relative valuation methord. Compared to the current price of 9.72 USD , Organon & Co is Undervalued By 50.91%.
Relative Value
Fair Zone
19.80-27.39
Current Price：9.72
50.91%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
4.74
P/B
Median3y
5.72
Median5y
2.77
30.01
FCF Yield
Median3y
13.18
Median5y
16.61
Competitors Valuation Multiple
The average P/S ratio for OGN's competitors is 5.53, providing a benchmark for relative valuation. Organon & Co Corp (OGN) exhibits a P/S ratio of 0.41, which is -92.50% above the industry average. Given its robust revenue growth of -6.72%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Organon & Co (OGN) currently overvalued or undervalued?
What is Organon & Co (OGN) fair value?
How does OGN's valuation metrics compare to the industry average?
What is the current P/B ratio for Organon & Co (OGN) as of Jul 08 2025?
What is the current FCF Yield for Organon & Co (OGN) as of Jul 08 2025?
What is the current Forward P/E ratio for Organon & Co (OGN) as of Jul 08 2025?